Biosynthesis of mannose from glucose via constructing phosphorylation-dephosphorylation reactions in Escherichia coli
Enzyme and Microbial Technology · 2024
DOI: 10.1016/j.enzmictec.2024.110427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Enzyme and Microbial Technology, 2024. Verfasst von Yuyao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin University of Science and Technology, National Engineering Laboratory for Industrial Enzymes, Tianjin 300457, China; National Engineering Lab…. Hauptthemen laut MEDLINE: Mannose, Escherichia coli, Glucose. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences Youth Innovation Promotion Association.
Abstract (Originalsprache)
d-mannose has been widely used in food, medicine, cosmetic, and food-additive industries. To date, chemical synthesis or enzymatic conversion approaches based on iso/epimerization reactions for d-mannose production suffered from low conversion rate due to the reaction equilibrium, necessitating intricate separation processes for obtaining pure products on an industrial scale. To circumvent this challenge, this study showcased a new approach for d-mannose synthesis from glucose through constructing a phosphorylation-dephosphorylation pathway in an engineered strain. Specifically, the gene encoding phosphofructokinase (PfkA) in glycolytic pathway was deleted in Escherichia coli to accumulate fructose-6-phosphate (F6P). Additionally, one endogenous phosphatase, YniC, with high specificity to mannose-6-phosphate, was identified. In ΔpfkA strain, a recombinant synthetic pathway based on mannose-6-phosphate isomerase and YniC was developed to direct F6P to mannose. The resulting strain successfully produced 25.2 g/L mannose from glucose with a high conversion rate of 63% after transformation for 48 h. This performance surpassed the 15% conversion rate observed with 2-epimerases. In conclusion, this study presents an efficient method for achieving high-yield mannose synthesis from cost-effective glucose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin University of Science and Technology, National Engineering Laboratory for Industrial Enzymes, Tianjin 300457, China; National Engineering Laboratory for Industrial Enzymes, Tianjin Institute of Industrial Biotec…
- National Engineering Laboratory for Industrial Enzymes, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China; University of Chinese Academy of Sciences, Beijing 100049, China.
- Tianjin University of Science and Technology, National Engineering Laboratory for Industrial Enzymes, Tianjin 300457, China.
- National Engineering Laboratory for Industrial Enzymes, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China. Electronic address: yang_jg1@tib.cas.cn.
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Sciences Youth Innovation Promotion Association
Zitieren
APA
Wang, Y., Chen, E., Wang, Y., Sun, X., Dong, Q., Chen, P., Zhang, C., Yang, J., & Sun, Y. (2024). Biosynthesis of mannose from glucose via constructing phosphorylation-dephosphorylation reactions in Escherichia coli. Enzyme and Microbial Technology. https://doi.org/10.1016/j.enzmictec.2024.110427
Vancouver
Wang Y, Chen E, Wang Y, Sun X, Dong Q, Chen P, et al. Biosynthesis of mannose from glucose via constructing phosphorylation-dephosphorylation reactions in Escherichia coli. Enzyme and Microbial Technology. 2024. doi:10.1016/j.enzmictec.2024.110427
BibTeX
@article{Wang2024,
author = {Wang, Yuyao and Chen, Enhui and Wang, Yanfei and Sun, Xinming and Dong, Qianzhen and Chen, Peng and Zhang, Chenglin and Yang, Jiangang and Sun, Yuanxia},
title = {Biosynthesis of mannose from glucose via constructing phosphorylation-dephosphorylation reactions in Escherichia coli},
journal = {Enzyme and Microbial Technology},
year = {2024},
doi = {10.1016/j.enzmictec.2024.110427}
}
EUVIMED